The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
The FDA has issued the guidance for industry, Certain Ophthalmic Products: Policy Regarding Compliance With 21 CFR Part 4. This guidance provides ...
read more
Teva Pharmaceuticals has reached an agreement with the Attorney General of Rhode Island that settles the state’s and its subdivisions opioid-related ...
read more
Bristol Myers Squibb announced that OpdualagTM (nivolumab and relatlimab-rmbw), a new, first-in-class, fixed-dose combination of nivolumab and ...
read more
The U.S. Food and Drug Administration approved the first generic of Symbicort (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol for ...
read more
AbbVie and Scripps Research announced a global collaboration to develop potential novel, direct-acting antiviral treatments for COVID-19.
read more
The FDA has issued a complete response letter (CRL) regarding the supplemental Biologics License Application (sBLA) for Fasenra (benralizumab) for ...
read more
AstraZeneca and MSD’s Lynparza (olaparib) has been approved in the US for the adjuvant treatment of patients with germline BRCA-mutated (gBRCAm) HER2-...
read more
Elektrofi & IPA announced they are entering into a collaboration to explore a high-concentration formulation of IPA’s COVID-19 antibody cocktail, ...
read more
Bristol Myers Squibb and Nektar Therapeutics announced an update following the first analysis of the Phase 3 PIVOT IO-001 study evaluating the doublet...
read more
Genetic Leap announced a research collaboration agreement with Astellas Pharma, Inc. to develop novel RNA-targeted small molecule therapeutic ...
read more
Wednesday, March 09, 2022
Bayer announced the submission of a supplemental new drug application (sNDA) to the FDA as well as the submission of a Variation Type II application ...
read more
BioNTech announced the expansion of its strategic collaboration with Regeneron to advance the Company’s FixVac candidate BNT116 in combination with ...
read more
UCB acquired Zogenix for US$ 26.00 per share plus a potential cash payment of $ 2.00 per share. The total transaction is valued at up to approximately...
read more
Harpoon Therapeutics announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for HPN328, a delta like ligand 3-...
read more
Servier, a leader in oncology committed to bringing the promise of tomorrow to the patients we serve, today announced that the U.S. Food and Drug ...
read more